​​​About the Project

Preeclampsia is a condition in pregnancy that can lead to severe health problems for both mother and child. Research has shown that women with a history of preeclampsia have a 2–3 times higher risk of developing cardiovascular diseases later in life, including heart failure and stroke. For this reason, Danish guidelines recommend that women with prior preeclampsia undergo lifelong annual follow-ups with blood pressure monitoring. However, studies suggest that many women and healthcare professionals are unaware of this increased risk as well as the recommendations for preventive follow-up. Research in this area is generally scarce, with a significant lack of studies on the long-term follow-up for cardiovascular disease after preeclampsia.

Within the CAPREE project we aim to enhance the understanding of the cross-sectoral care pathway for women with preeclampsia – from diagnosis to long-term follow-up. The project explores factors associated with lack of follow-up care among women with prior preeclampsia and identifies groups at particularly high risk of developing cardiovascular disease later in life. This is expected to enable the identification of potential focus areas and contribute to the development and pilot-testing of targeted intervention activities to reduce the risk of cardiovascular disease.

The CAPREE project is funded by a grant from The Danish Heart Foundation (Hjerteforeningen).

O​​​bjec​​​​tive

The aim of the CAPREE project is to build the evidence-base, and develop, as well as pilot test specific inte​​​rvention activities that can improve follow-up and, in the long term, reduce the risk of cardiovascular diseases in women with prior preeclampsia. The project has four specific objectives:

1. Identifying Barriers and​​ Facilitators

   To investigate which factors at the individual, family, and healthcare system levels hinder or promote long-term prevention and early detection of cardiovascular diseases in women with prior preeclampsia.

2. ​Identifying High-Ri​​sk Groups

   To identify and characterise women with prior preeclampsia who are at the highest risk of cardiovascular diseases and related conditions.

3. Developing Targ​​eted Interventions

   To develop specific intervention activities aimed at improving care pathways, prevention, and detection of cardiovascular diseases in women with prior preeclampsia. These activities will be co-created with the target group and other key stakeholders.

4. Pilot Testing Interv​entions

   To pilot test the developed interventions in order to improve care pathways, prevention, and detection of cardiovascular diseases in women with prior preeclampsia.
   

C​ollabo​rators

• Rigshospitalet
  
• Aarhus University​​